NPJ precision oncology.
Saved in:
VerfasserIn: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | [London] : : Springer Nature,, [2017]- |
Publication history: | Began with 1:1 (2017). |
Language: | English |
Physical Description: | 1 online resource |
Notes: | Refereed/Peer-reviewed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 00000nas-a2200541-i-4500 | ||
---|---|---|---|
001 | 993574942704498 | ||
005 | 20230815213017.0 | ||
006 | m-----o--d-------- | ||
007 | cr-||||||||||| | ||
008 | 170623c20179999enkmr-p-o-----0----0eng-- | ||
010 | |a 2017243199 | ||
015 | |a GBB854211 |2 bnb | ||
016 | 7 | |a 101708166 |2 DNLM | |
016 | 7 | |a 017740954 |2 Uk | |
035 | |a (DE-599)ZDB2891458-2 | ||
035 | |a (OCoLC)995231447 | ||
035 | |a (CKB)3790000000132559 | ||
035 | |a (CONSER)--2017243199 | ||
035 | |a (NjHacI)993790000000132559 | ||
035 | |a (EXLCZ)993790000000132559 | ||
040 | |a NjHacI |b eng |e rda |c NjHacI | ||
042 | |a pcc | ||
050 | 4 | |a RB155 |b .H676 2017 | |
060 | 0 | 0 | |a W1 |
082 | 0 | 4 | |a 616.042 |2 23 |
110 | 2 | |a Hormel Institute, |e author, |e issuing body. | |
210 | |a NPJ PRECIS ONCOL | ||
210 | 1 | 0 | |a NPJ Precis Oncol |2 dnlm |
245 | 0 | 0 | |a NPJ precision oncology. |
246 | 1 | |a Nature Partner Journals precision oncology | |
246 | 1 | |a Precision oncology | |
264 | 1 | |a [London] : |b Springer Nature, |c [2017]- | |
300 | |a 1 online resource | ||
310 | |a Monthly | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
362 | 1 | |a Began with 1:1 (2017). | |
500 | |a Refereed/Peer-reviewed | ||
506 | 0 | |f Unrestricted online access |2 star | |
588 | |a Description based on: 1:1 (2017); title from PDF article running title (publisher's Web site, viewed July 19, 2017). | ||
588 | |a Latest issue consulted: 1:23 (2017) (viewed July 19, 2017). | ||
505 | 0 | |a Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling -- Live-single-cell phenotypic cancer biomarkers-future role in precision oncology? -- Precision oncology- the future of personalized cancer medicine? -- Circulating tumor cells: quintessential precision oncology presenting challenges for biology -- Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma -- EBV based cancer prevention and therapy in nasopharyngeal carcinoma -- Endothelial cell malignancies: new insights from the laboratory and clinic -- Revisiting the IGF-1R as a breast cancer target -- Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic -- Targeting the duality of cancer -- Network-based machine learning and graph theory algorithms for precision oncology -- Immune cell profiling in cancer: molecular approaches to cell-specific identification -- Addressing the challenges of applying precision oncology -- Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care -- Towards personalized tumor markers -- Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. | |
650 | 0 | |a Precision medicine |v Periodicals. | |
650 | 0 | |a Tumors |v Periodicals. | |
650 | 1 | 2 | |a Precision Medicine. |
650 | 0 | |a Precision Medicine |v Periodicals. | |
650 | 2 | 2 | |a Neoplasms. |
650 | 7 | |a Precision medicine. |2 fast |0 (OCoLC)fst01910010 | |
650 | 7 | |a Tumors. |2 fast |0 (OCoLC)fst01158759 | |
655 | 4 | |a Fulltext. | |
655 | 2 | |a Periodical. | |
655 | 7 | |a Periodicals. |2 fast |0 (OCoLC)fst01411641 | |
655 | 4 | |a Periodicals. | |
655 | 4 | |a Internet Resources. | |
776 | |x 2397-768X | ||
710 | 2 | |a Hormel Institute, |e publisher. | |
906 | |a JOURNAL | ||
ADM | |b 2024-03-23 03:54:41 Europe/Vienna |f system |c marc21 |a 2017-05-17 08:05:44 Europe/Vienna |g false | ||
AVE | |i DOAJ Directory of Open Access Journals |P DOAJ Directory of Open Access Journals |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342102260004498&Force_direct=true |Z 5342102260004498 |m Available from 2017. |b Available |8 5342102260004498 | ||
AVE | |Z 5342102260004498 |A 2017 |